Cover Image
市場調查報告書

Ascletis Inc. 的產品平台分析

Ascletis Inc. - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 319962
出版日期 內容資訊 英文 29 Pages
訂單完成後即時交付
價格
Back to Top
Ascletis Inc. 的產品平台分析 Ascletis Inc. - Product Pipeline Review - 2014
出版日期: 2014年11月24日 內容資訊: 英文 29 Pages
簡介

Ascletis Inc. 是總公司設置於美國的生物製藥企業,正在針對中國市場,研發癌症及傳染疾病治療藥。平台產品有HCV,HIV,肝癌的治療藥。

本報告提供Ascletis Inc. 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,並彙整最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Ascletis Inc. 的基本資料

  • Ascletis Inc. 概要
  • 主要資訊
  • 企業資料

Ascletis Inc. :R&D概要

  • 主要的治療範圍

Ascletis Inc. :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

Ascletis Inc. :開發中產品概況

  • 臨床階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 藥物研發階段的產品/聯合治療模式

Ascletis Inc. :藥物簡介

  • danoprevir
  • PPI-668
  • TMC-310911
  • ASC-01

Ascletis Inc. :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Ascletis Inc. :最新的開發平台資訊

Ascletis Inc. :開發暫停中的計劃

Ascletis Inc. :開發中止的產品

Ascletis Inc. :總公司和子公司的所在地

  • 總公司
  • 分公司及子公司

附錄

圖表一覽

目錄
Product Code: GMDHC06515CDB

Summary

Global Markets Direct's, 'Ascletis Inc. - Product Pipeline Review - 2014', provides an overview of the Ascletis Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Ascletis Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Ascletis Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Ascletis Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Ascletis Inc.'s pipeline products

Reasons to buy

  • Evaluate Ascletis Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Ascletis Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Ascletis Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Ascletis Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Ascletis Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Ascletis Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Ascletis Inc. Snapshot
    • Ascletis Inc. Overview
    • Key Information
    • Key Facts
  • Ascletis Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Ascletis Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Ascletis Inc. - Pipeline Products Glance
    • Ascletis Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Ascletis Inc. - Early Stage Pipeline Products
      • Discovery Products/Combination Treatment Modalities
  • Ascletis Inc. - Drug Profiles
    • danoprevir
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PPI-668
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TMC-310911
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ASC-01
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Ascletis Inc. - Pipeline Analysis
    • Ascletis Inc. - Pipeline Products by Target
    • Ascletis Inc. - Pipeline Products by Route of Administration
    • Ascletis Inc. - Pipeline Products by Molecule Type
    • Ascletis Inc. - Pipeline Products by Mechanism of Action
  • Ascletis Inc. - Recent Pipeline Updates
  • Ascletis Inc. - Dormant Projects
  • Ascletis Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Ascletis Inc., Key Information
  • Ascletis Inc., Key Facts
  • Ascletis Inc. - Pipeline by Indication, 2014
  • Ascletis Inc. - Pipeline by Stage of Development, 2014
  • Ascletis Inc. - Monotherapy Products in Pipeline, 2014
  • Ascletis Inc. - Partnered Products in Pipeline, 2014
  • Ascletis Inc. - Partnered Products/ Combination Treatment Modalities, 2014
  • Ascletis Inc. - Phase II, 2014
  • Ascletis Inc. - Discovery, 2014
  • Ascletis Inc. - Pipeline by Target, 2014
  • Ascletis Inc. - Pipeline by Route of Administration, 2014
  • Ascletis Inc. - Pipeline by Molecule Type, 2014
  • Ascletis Inc. - Pipeline Products by Mechanism of Action, 2014
  • Ascletis Inc. - Recent Pipeline Updates, 2014
  • Ascletis Inc. - Dormant Developmental Projects,2014
  • Ascletis Inc., Other Locations

List of Figures

  • Ascletis Inc. - Pipeline by Top 10 Indication, 2014
  • Ascletis Inc. - Pipeline by Stage of Development, 2014
  • Ascletis Inc. - Monotherapy Products in Pipeline, 2014
  • Ascletis Inc. - Pipeline by Top 10 Target, 2014
  • Ascletis Inc. - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top